Asthma and lower airway diseaseAmbient pollen concentrations and emergency department visits for asthma and wheeze
Section snippets
Pollen data
Airborne pollen concentrations were measured by the Atlanta Allergy and Asthma Clinic, a member of the National Allergy Bureau, between January 1, 1993, and December 31, 2004 (Fig 1). The monitoring site was moved once on January 1, 2000; pollen was sampled from the same rooftop height at both locations and away from vegetation, air conditioners, and building vents. National Allergy Bureau–certified Atlanta Allergy and Asthma Clinic staff analyzed air samples 5 days per week (Sunday-Thursday)
Descriptive statistics
Over the 1993-2004 time period, there were 400,819 ED visits for asthma and wheeze (0-4 years = 108,147 visits; 5-17 years = 91,386 visits, and ≥18 years = 201,286 visits). ED visits are further described in Table E1 in this article's Online Repository at www.jacionline.org. Raw data plots shown in Fig E1 in this article's Online Repository at www.jacionline.org demonstrate recurrent seasonal patterns of ED visits. Ambient pollen concentrations were highly skewed, with concentrations that were
Discussion
Overall, these results suggest that ambient pollen, in particular Quercus species and Poaceae pollen, independently contribute to asthma morbidity in Atlanta. We observed a 2% to 3% increased risk of asthma-related ED visits per SD increase in pollen levels and a corresponding 10% to 15% increase in risk on days with the highest concentrations (comparing the top 5% of days with the lowest 50% of days) for Quercus species and Poaceae pollen. The magnitudes of association observed are similar to
References (31)
- et al.
Influence of outdoor aeroallergens on hospitalization for asthma in Canada
J Allergy Clin Immunol
(2004) - et al.
Relationship of outdoor air quality to pediatric asthma exacerbations
Ann Allergy Asthma Immunol
(2003) - et al.
Climate change and allergic disease
J Allergy Clin Immunol
(2008) - et al.
Localization, release and bioavailability of pollen allergens: the influence of environmental factors
Curr Opin Immunol
(2001) Interpreting atmospheric pollen counts for use in clinical allergy: allergic symptomology
Ann Allergy Asthma Immunol
(2001)- et al.
The September epidemic of asthma hospitalization: school children as disease vectors
J Allergy Clin Immunol
(2006) - et al.
Associations between grass and weed pollen and emergency department visits for asthma among children in Montreal
Environ Res
(2008) - et al.
Spatial variability in the pollen count in Sydney, Australia: can one sampling site accurately reflect the pollen count for a region?
Ann Allergy Asthma Immunol
(2004) - et al.
Production of allergenic pollen by ragweed (Ambrosia artemisiifolia L.) is increased in CO(2)-enriched atmospheres
Ann Allergy Asthma Immunol
(2002) - et al.
Tree pollen and hospitalization for asthma in urban Canada
Int Arch Allergy Immunol
(2008)
Association between airborne pollen and epidemic asthma in Madrid, Spain: a case-control study
Thorax
Association between tree pollen counts and asthma ED visits in a high-density urban center
J Asthma
Short term effects of airborne pollen concentrations on asthma epidemic
Thorax
Role of outdoor aeroallergens in asthma exacerbations: epidemiological evidence
Thorax
Urban air pollution and climate change as environmental risk factors of respiratory allergy: an update
J Investig Allergol Clin Immunol
Cited by (142)
How climate change degrades child health: A systematic review and meta-analysis
2024, Science of the Total EnvironmentThe effects of tree planting on allergenic pollen production in New York City
2024, Urban Forestry and Urban GreeningMachine learning methods for low-cost pollen monitoring – Model optimisation and interpretability
2023, Science of the Total EnvironmentPollen and asthma morbidity in Atlanta: A 26-year time-series study
2023, Environment InternationalPollen, respiratory viruses, and climate change: Synergistic effects on human health
2023, Environmental ResearchMolecular allergology approach to allergic asthma
2022, Molecular Aspects of Medicine
Supported by the Centers for Disease Control and Prevention (TKC Global Solutions, LLC: JR5000139), the US Environmental Protection Agency (USEPA; RD834799), and the National Institute of Environmental Health Sciences (NIEHS; R03ES018963). Creation of the emergency department database was supported by the USEPA (RD833626), the NIEHS (R01ES11294), and the Electric Power Research Institute (EP-P277231/C13172). The content of this publication is solely the responsibility of the grantee and does not necessarily represent the official views of the USEPA. Furthermore, USEPA does not endorse the purchase of any commercial products or services mentioned in the publication.
Disclosure of potential conflict of interest: L. A. Darrow and M. Klein have received research support from the National Institute of Environmental Health Sciences, the US Environmental Protection Agency (EPA), the Electric Power Research Institute, and the Centers for Disease Control and Prevention (CDC). J. Hess has received research support from the CDC. P. E. Tolbert has received research support from the EPA, the Electric Power Research Institute, the National Institutes of Health, and the CDC. S. E. Sarnat has received research support from the EPA and the Electric Power Research Institute. C. A. Rogers declares that she has no relevant conflicts of interest.